VomitingAntiemeticsNauseaQuinuclidinesSerotonin 5-HT3 Receptor AntagonistsGranisetronOndansetronIsoquinolinesAntineoplastic AgentsSerotonin AntagonistsCancer Care FacilitiesDexamethasoneMorpholinesDouble-Blind MethodNeoplasmsDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeProspective StudiesDrug Therapy, CombinationCyclophosphamideVincristineDoxorubicinFluorouracilAnti-HIV AgentsCisplatinCombined Modality TherapyEtoposideDose-Response Relationship, DrugSurvival AnalysisAdministration, OralInfusions, IntravenousTime FactorsHIV InfectionsDisease-Free SurvivalPrednisoneTransplantation ConditioningAnti-Bacterial AgentsMethotrexateRemission InductionSalvage TherapySurvival RateDeoxycytidineLeucovorinRetrospective StudiesDrug CombinationsTreatment FailureImmunosuppressive AgentsVinblastineCytarabineRecurrenceAntiretroviral Therapy, Highly ActiveBusulfanFollow-Up StudiesBenzoxazinesHematopoietic Stem Cell TransplantationPaclitaxelClinical Trials as TopicPatient ComplianceVidarabineAntitubercular AgentsOrganoplatinum CompoundsHIV Protease InhibitorsTaxoidsIfosfamideNeutropeniaBleomycinRifampinRitonavirCarboplatinViral LoadLymphoma, Non-HodgkinTransplantation, AutologousWhole-Body IrradiationReverse Transcriptase InhibitorsEpirubicinTransplantation, HomologousNevirapineArea Under CurveAmoxicillinCamptothecinAntineoplastic Agents, AlkylatingPrognosisBone Marrow TransplantationMelphalanPyrazinamideChemotherapy, AdjuvantIsoniazidHIV-1Neoplasm StagingCD4 Lymphocyte CountDrug Resistance, ViralLung NeoplasmsInjections, IntravenousDrug EvaluationClarithromycinAntimetabolites, AntineoplasticRandomized Controlled Trials as TopicProcarbazineBreast Neoplasms